PTC Therapeutics

PTC Therapeutics, as a science-driven global biopharmaceutical company, combines our strong clinical and scientific expertise with a commitment to leveraging groundbreaking science and new technologies to find innovative treatments for these diseases, thereby providing patients and their families with more time. Since 1998, PTC has been a biopharmaceutical company focused on innovative small molecule and gene therapies for rare genetic disorders. We have offices and/or research laboratories in more than 20 countries and operate in over 50 countries worldwide. We also boast robust commercial performance and a strong capital position.